Leptin is increased in MS patients and adversely correlated with Foxp3 gene expression in PBMCs, which plays a role in suppressing immune function, and is positively related to TNF-α, IL-1β, and hsCRP levels [56]. This evidence concerns the gene LEP and myeloid sarcoma.